Top Menu

Archive | DTC News

Register for GOLD – Best Value for the DTC National 2012

  The DTC National Gold Pass is the ‘Best Value’ Option for Attendees interested in the full DTC National experience. From streamlining the check-in process to post-conference access of the conference videos, the Gold Pass includes a great bundle of conference elements. Attend the pre-conference workshop on targetted DTC marketing options and use your $199 […]

Continue Reading

New Study Wants More FDA DTC Explanations

New Study Wants More FDA DTC Explanations “The authors feel consumers misunderstand what FDA approval means.” -Bob Ehrlich Two physician researchers, Drs. Schwartz and Woloshin, have studied and published on DTC for years. They have generally been critical of drug industry communications. In their latest study published 9/12/2011 in the journal “Archives of Internal Medicine”, […]

Continue Reading

DTC Digital Frustration

“Drug company management is in a defensive posture.” -Bob Ehrlich I just returned from our annual digital DTC conference in New Jersey. I can describe the general sentiment as one of frustration. That is, frustration with FDA and their glacial movement on guidance, frustration with the pharma industry on their reluctance to take risks, and […]

Continue Reading

Bob Ehrlich’s blog on blogs – August 19, 2008

John Mack in his Pharma Marketing Blog of 8/14 wrote an interesting piece called Rethinking the Value of DTC Advertising . Mack says that the numbers of patients who visit and ask doctors about advertised drugs is very low. Therefore, he wonders how the expenditures can pay back on this low a number of patient […]

Continue Reading